AZILECT
TEVA CANADA LIMITED
Quick answers
Is there a shortage of AZILECT in Canada?
No. There is no current shortage of AZILECT 1MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TEVA-RASAGILINE
TEVA CANADA LIMITED
AG-RASAGILINE
ANGITA PHARMA INC.
ASN-RASAGILINE
ASCEND LABORATORIES LTD
MINT-RASAGILINE
MINT PHARMACEUTICALS INC
Other Products
APO-RASAGILINE
APOTEX INC
AZILECT
TEVA CANADA LIMITED
DIN
02284650
Strength
1MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
RASAGILINE (RASAGILINE MESYLATE)
See all RASAGILINE (RASAGILINE MESYLATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646